Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd (ASX: OVN) is pleased to announce its Appendix 4C and quarterly business activities review for the three-month period ended 31 March 2020 (Q3 FY2020).
For more information, download the attached PDF.
Download this document
